SEC Form 4 · accession 0001140361-16-050315
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander J Denner
Director
Period of report
Feb 2, 2016
Accepted (ET)
Feb 4, 2016 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Call Option (right-to-buy)F1 | $32.86 | Feb 2, 2016 | A | 27,230 | A | — | Feb 2, 2026 | Common Stock | 27,230 | 27,230 | D |
Explanation of responses
- F1This option vests in one installment on February 2, 2019 and is made as part of and pursuant to Issuer's director compensation package.